Vitamin d receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP)

Molecular Endocrinology

Volumn 25, Issue 8, 2011, Pages 1289-1300

  Menegaz, Danusa ^a,b   Mizwicki, Mathew T ^a   Barrientos Duran, Antonio ^a   Chen, Ning ^a   Henry, Helen L ^a   Norman, Anthony W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; CHLORIDE CHANNEL BLOCKING AGENT; CURCUMIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VOLTAGE GATED CHLORINE CHANNEL;

ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; MUTATION; PRIORITY JOURNAL; SERTOLI CELL; WILD TYPE;

ANIMALS; BINDING SITES; CALCIFEDIOL; CERCOPITHECUS AETHIOPS; CHLORIDE CHANNELS; COS CELLS; CURCUMIN; DRUG SYNERGISM; ERGOSTEROL; GENOME; HUMANS; ION CHANNEL GATING; LIGANDS; MALE; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CALCITRIOL; SERTOLI CELLS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 79960978543     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0442     Document Type: Article

References (50)

1. Wu RC, Feng Q, Lonard DM, O'Malley BW 2007 SRC-3 coacti-vator functional lifetime is regulated by a phospho-dependent ubiq-uitin time clock. Cell 129:1125-1140
2. Norman AW, Mizwicki MT, Norman DPG 2004 Steroid hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3:27-41
3. Lonard DM, Lanz RB, O'Malley BW 2007 Nuclear receptor co-regulators and human disease. Endocr Rev 28:575-587
4. Levin ER 2005 Integration of the extra-nuclear and nuclear actions of estrogen. Mol Endocrinol 19:1951-1959
5. Pietras RJ, Nemere I, Szego CM 2001 Steroid hormone receptors in target cell membranes. Endocrine 14:417-427
6. Mizwicki MT, Norman AW 2009 The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci Signal 2:re4
7. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M 2005 Palmitoylation-dependent estrogen receptor a membrane localization: regulation by 17β-estradiol. Mol Biol Cell 16:231-237
8. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP 2001 Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276:13442-13451
9. Pojoga LH, Adamova Z, Kumar A, Stennett AK, Romero JR, Adler GK, Williams GH, Khalil RA 2010 Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol 298:H1776-H1788
10. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW 2004 The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1a,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18:2660-2671
11. Zhao G, Simpson RU 2009 Membrane localization, caveolin-3 association and rapid actions of vitamin D receptor in cardiac myocytes. Steroids 75:555-559
12. Zhao G, Simpson RU 2010 Interaction between vitamin D receptor with caveolin-3 and regulation by 1,25-dihydroxyvitamin D3 in adult rat cardiomyocytes. J Steroid Biochem Mol Biol 121:159-163
13. Mizwicki MT, Bula CM, Mahinthichaichan P, Henry HL, Ishizuka S, Norman AW 2009 On the mechanism underlying (23S)-25-dehydro-1a(OH)-vitamin D3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonist. J Biol Chem 284:36292-36301
14. Norman AW, Ishizuka S, Okamura WH 2001 Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 76:49-59
15. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK 1997 The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 154:S57-S73
16. Mizwicki MT, Keidel D, Bula CM, Bishop JE, Zanello LP, Wurtz JM, Moras D, Norman AW 2004 Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1a,25(OH)2-vitamin D3 signaling. Proc Natl Acad Sci USA 101:12876-12881
17. Norman AW, Bouillon R, Farach-Carson MC, Bishop JE, Zhou LX, Nemere I, Zhao J, Muralidharan KR, Okamura WH 1993 Demonstration that 1β,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1a,25-dihydroxyvi-tamin D3. J Biol Chem 268:20022-20030
18. Zanello LP, Norman AW 2004 Rapid modulation of osteoblast ion channel responses by 1a,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101:1589-1594
19. Menegaz D, Barrientos-Duran A, Kline A, Silva FR, Norman AW, Mizwicki MT, Zanello LP 2010 1a,25(OH)2-vitamin D3 stimulation of secretion via chloride channel activation in Sertoli cells. J Steroid Biochem Mol Biol 119:127-134
20. Norman AW, Okamura WH, Hammond MW, Bishop JE, Dormanen MC, Bouillon R, van Baelen H, Ridall AL, Daane E, Khoury R, Farach-Carson MC 1997 Comparison of 6-s-cis and 6-s-trans locked analogs of 1a,25(OH)2-vitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis nor 6-s-trans locked analogs are preferred for genomic biological responses. Mol Endocrinol 11:1518-1531
21. 2+ concentration in pancreatic β-cells through nongenomic signal transduction. Endocrinology 140:4706-4712
22. Rebsamen MC, Sun J, Norman AW, Liao JK 2002 1a,25-dihy-droxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91:17-24
23. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D 2000 The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5:173-179
24. Weatherman RV, Fletterick RJ, Scanlan TS 1999 Nuclear receptor ligands and ligand-binding domains. Annu Rev Biochem 68:559-582
25. Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, Furmick JK, Hernandez Z, Haussler CA, Haussler MR, Ju-rutka PW 2010 Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemo-prevention. J Nutr Biochem 21:1153-1161
26. Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, Hsieh JC, Kaczmarska M, Haussler CA, Haussler MR 2007 Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res 22(Suppl 2):V2-V10
27. Mizwicki MT, Menegaz D, Yaghmaei S, Henry HL, Norman AW 2010 A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications. J Steroid Biochem Mol Biol 121:98-105
28. Yin Z, Watsky MA 2005 Chloride channel activity in human lung fibroblasts and myofibroblasts. Am J Physiol Lung Cell Mol Physiol 288:L1110-L1116
29. Akerstrom VL, Walters MR 1992 Physiological effects of 1,25-dihydroxyvitamin D3 in TM4 sertoli cell line. Am J Physiol Endocrinol Metab 262:E884-E890
30. Norman AW 2005 1a,25(OH)2-vitamin D3 mediated rapid and genomic responses are dependent upon critical structure-function relationships for both the ligand and receptor(s). In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. 2nd ed. San Diego: Elsevier Academic Press; 381-407
31. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER 2003 Identification of a structural determinant necessary for the localization and function of estrogen receptor a at the plasma membrane. Mol Cell Biol 23:1633-1646
32. Chambliss KL, Simon L, Yuhanna IS, Mineo C, Shaul PW 2005 Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERa domains with known nuclear functions. Mol Endocrinol 19:277-289
33. Hurwitz S, Cooke NE 2003 Vitamn D-binding protein. In: Henry HL, Norman AW, eds. Encyclopedia of hormones. San Diego: Academic Press; 602-609
34. Norman AW, Olivera CJ, Barreto Silva FR, Bishop JE 2002 A specific binding protein/receptor for 1a,25-dihydroxy D3 is present in an intestinal caveolae membrane fraction. Biochem Biophys Res Commun 298:414-419
35. Norman AW, Bishop JE, Collins ED, Seo EG, Satchell DP, Dormanen MC, Zanello SB, Farach-Carson MC, Bouillon R, Okamura WH 1996 Differing shapes of 1a,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report. J Steroid Biochem Mol Biol 56:13-22
36. Nemere I, Farach-Carson MC, Rohe B, Sterling TM, Norman AW, Boyan BD, Safford SE 2004 Ribozyme knockdown functionally links a 1a,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. Proc Natl Acad Sci USA 101:7392-7397
37. Chen J, Olivares-Navarrete R, Wang Y, Herman TR, Boyan BD, Schwartz Z 2010 Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1a,25-dihydroxyvitamin D3 in osteoblasts. J Biol Chem 285:37041-37050
38. Wang Y, Chen J, Lee CS, Nizkorodov A, Riemenschneider K, Martin D, Hyzy S, Schwartz Z, Boyan BD 2010 Disruption of Pdia3 gene results in bone abnormality and affects 1a,25-dihydroxy-vita-min D3-induced rapid activation of PKC. J Steroid Biochem Mol Biol 121:257-260
39. Wu W, Beilhartz G, Roy Y, Richard CL, Curtin M, Brown L, Cadieux D, Coppolino M, Farach-Carson MC, Nemere I, Meckling KA 2010 Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkB in differentiating NB4 leukemia cells. Exp Cell Res 316:1101-1108
40. Biswas P, Zanello LP 2009 1,25(OH)2-vitamin D3 induction of ATP secretion in osteoblasts. J Bone Miner Res 24:1450-1460
41. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y 2000 Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 141:1317-1324
42. Auzanneau C, Norez C, Noel S, Jougla C, Becq F, Vandebrouck C 2006 Pharmacological profile of inhibition of the chloride channels activated by extracellular acid in cultured rat Sertoli cells. Reprod Nutr Dev 46:241-255
43. Rato L, Socorro S, Cavaco JE, Oliveira PF 2010 Tubular fluid secretion in the seminiferous epithelium: ion transporters and aqua-porins in Sertoli cells. J Membr Biol 236:215-224
44. Silva FR, Leite LD, Wassermann GF 2002 Rapid signal transduction in Sertoli cells. Eur J Endocrinol 147:425-433
45. Jentsch TJ, Stein V, Weinreich F, Zdebik AA 2002 Molecular structure and physiological function of chloride channels. Physiol Rev 82:503-568
46. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K, Wehling M 2003 Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 83:965-1016
47. Dixon KM, Deo SS, Norman AW, Bishop JE, Halliday GM, Reeve VE, Mason RS 2007 In vivo relevance for photoprotection by the vitamin D rapid response pathway. J Steroid Biochem Mol Biol 103:451-456
48. Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffery A, Mahanian M, Liu PT, Hewison M, Mizwicki M, Cashman J, Fiala M 2009 1a,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-b clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis 17: 703-717
49. Mizwicki MT, Bula CM, Bishop JE, Norman AW 2005 A perspective on how the vitamin D sterol/vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified vitamin D sterols. J Steroid Biochem Mol Biol 57:69-82
50. Dixon KM, Norman AW, Sequeira VB, Mohan R, Rybchyn MS, Reeve VE, Halliday GM, Mason RS July 6, 2011 1a,25(OH)2-vitamin D and a non-genomic vitamin D analog inhibit ultraviolet radiation-induced skin carcinogenesis. Cancer Prev Res (Phila) 10.1158/1940-6207.CAPR-11-0165